Navigation Links
Is venture capital dead? No, but its beginning a new cycle

ed in 2002 and through most of 2003, but rebounded in 2004, when about $20 billion was invested. A similar pace is expected in 2005.

Whats happening today is long-term, reasoned investment, Heeson said.

Gone are the days when VCs announced they would raise $250 million for a fund but accepted $500 million or more, simply because the money was available. Heeson said venture capi......

Full article >>>
'"/>

Source:wistechnology.com By Tom Still 06/22/05


Page: 1 2 3

Related biology technology :

1. Investor warns of angel-venture funding gap
2. Visions: Broderick says Wisconsin should be in top third in venture capital
3. Wisconsin building toward the major leagues of venture capital
4. Biotech officials praise focus of new venture fund
5. Alzheimers drug developer lands $1.2M in venture funding
6. Capital-raising term sheets for angels and venture capitalists
7. Visions: Carbone bullish on Wisconsin venture capital
8. Wisconsin firms to present at Cleantech venture capital event
9. Doyle proposes $2M for venture capital center
10. Wisconsin fares slightly better in venture capital chase
11. State agencies propose venture capital center

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: venture capital dead but its beginning new cycle

(Date:12/2/2009)..., JERUSALEM, Israel, December 2 /PRNewswire/...y evaluating the preclinical (animal study) safety...ines technology from Weill,Cornell Medical College...o,treat inherited anemias such as Cooley,s Anemia....technologies to expand, ex vivo,populations of st...
(Date:12/2/2009)..., SINGAPORE, Dec. 2 S*BIO Pte Ltd...ral JAK2 inhibitor, SB1518, at The American Societ... in New Orleans. ,, Data will be presented on t...on trial of SB1518 detailing its safety, tolerabil...ofile in dose levels ranging from 100 to 600 mg. T...
(Date:12/2/2009)... RESTON, Va., Dec. 2 /PRNewswire-Asia-FirstCall...Company") (OTC Bulletin Board: EMDY), a leading,pr...rmula, milk powder and,soybean products in China, ...in the Spring issue of US Food & Drink Executi... 250,000 executives in the food and beverage indus...
(Date:12/2/2009)... NANJING, China, Dec. 2 /PRNewswire-Asia/ -- Si...any") (NYSE: SCR ), a leading pharmaceutical com...g, and marketing of branded,generic and proprietar...05 of,its drugs have been included in China,s Nati...ssued by China,s Ministry of Human Resources and S...
Breaking Biology Technology:Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Emerald Dairy To Be Featured in Spring Issue of US Food and Drink Executive 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3
... LELYSTAD, Netherlands, March 3, Genmab A/S (OTC: ...research collaboration aimed at identifying fully,...sease targets.,Intractable targets include those t...ble technologies but are highly desirable for targ...es can for example be due to the,fact that target ...
...3 Vermillion, Inc.,(Nasdaq: VRML ), a high-value...at it has entered into an exclusive license agreem...cialize a novel biomarker panel used to,assess the...d to affect up,to 12 million Americans, PAD is a s...disease can result in severe complications, includ...
...iMedx, Inc., a development-stage,medical device co...n,appointed President. In this role, Mr. Splan wil...o the MiMedx team., Throughout his 34-year career...ity to manage a wide range of operations and deliv...s. Beginning in 1986, Mr. Splan was,employed by Sm...
Other Biology Technology:Genmab and Pepscan to Identify Human Antibodies Against Intractable Targets 2Genmab and Pepscan to Identify Human Antibodies Against Intractable Targets 3Vermillion and Stanford University Sign Exclusive License Agreement for Novel Biomarker Panel to Assess Peripheral Artery Disease Risk 2Vermillion and Stanford University Sign Exclusive License Agreement for Novel Biomarker Panel to Assess Peripheral Artery Disease Risk 3MiMedx Announces Brian J. Splan as President 2
(Date:12/1/2009)... is pleased to announce the publication of results...e efficacy and tolerability of its novel, intranas...f chronic rhinosinusitis with nasal polyps in Rhi... and European Rhinologic Societies. , Chronic r...se that can significantly reduce a patient,s quali...
(Date:12/1/2009)...s disease, nerve cell degeneration plays a crucial...possibly be derived from steering the generation a...n published in the current issue of the renowned j...rs ago, neurogenesis the process of nerve cell de...adult brain. The textbooks asserted that dead nerv...
(Date:12/1/2009)... University cancer researchers have developed a t...ells and blocks the growth of new tumor blood vess...d to kill cancer cells oncolytic viruses might b...f they also carry a gene for a protein that inhibi...culostatin, is normally produced in the brain. In ...
Breaking Biology News(10 mins):New data on highly effective treatment for chronic rhinosinusitis with nasal polyps 2New source discovered for the generation of nerve cells in the brain 2Tumor-attacking virus strikes with 'one-two punch' 2Federal stimulus funding channels more than 2440 million to Fred Hutchinson Cancer Research Center 58955 1Federal stimulus funding channels more than 2440 million to Fred Hutchinson Cancer Research Center 58955 2Federal stimulus funding channels more than 2440 million to Fred Hutchinson Cancer Research Center 58955 3GTRI is developing protocols for testing effects of RFID systems on medical devices 58950 1GTRI is developing protocols for testing effects of RFID systems on medical devices 58950 2GTRI is developing protocols for testing effects of RFID systems on medical devices 58950 3Eating liquorice in pregnancy may affect a childs IQ and behavior 10273 1Eating liquorice in pregnancy may affect a childs IQ and behavior 10273 2
...ng, believed to be one of the detrimental effects ... through effective local management, according to ... long-term recovery of coral reefs in Palau and el...esilient and can bounce back magnificently if subj... so of pristine conditions," says Robert van Woesi...
...e University of California-Davis recently develope...r among bacteria in the environment. Researchers b...s by taking into account characteristics of the na...a hangouts. This model will help scientists to qua...The swapping of genetic material between bacteria ...
...ng for creatures that live in the deepest parts of...one living in the unlikeliest of habitats ?the car...ay that discovering a new sea anemone isn,t so unu... is what sets this new creature apart. , Since ...eren,t sea anemone specialists, they sent the 10 s...
Other Biology News:Palau's coral reefs show differential habitat recovery following the 1998 bleaching event 2Researchers develop way to calculate speed of bacterial sex 2From the deep -- Researchers find new species of sea anemone 2From the deep -- Researchers find new species of sea anemone 3
Mouse Anti-Rat RT1Bu (Class II Polymorphic) Monoclonal Antibody, Biotin Conjugated from AbD Serotec
Mouse Anti-Guinea Pig T-Cells, Pan Monoclonal Antibody, FITC Conjugated from AbD Serotec
Mouse Anti-Rabbit T LYMPHOCYTES Monoclonal Antibody, Unconjugated, Clone KEN-5 from AbD Serotec
Canine Serum from CHEMICON
Biology Products: